Table 1.
Correlation between aberrant glycosylation of CD147/basigin mediated by GnT‐V and prognostic variables in 51 HCC patients. Statistical significance of differences between groups was analyzed by the Wilcoxon rank sum test
| PLA signal CD147/PHA‐L | ||
|---|---|---|
| Variable | Median (minimum–maximum) | P value |
| Sex | 0.375 | |
| Male (n = 38) | 13.48 (5.41–30.48) | |
| Female (n = 11) | 11.43 (8.07–18.37) | |
| Age (years) | 0.829 | |
| <50 (n = 22) | 11.63 (5.41–30.80) | |
| ≥50 (n = 15) | 12.8 (6.04–20.40) | |
| Liver cirrhosis | 0.335 | |
| Yes (n = 30) | 13.64 (5.41–30.48) | |
| No (n = 19) | 11.43 (7.59–20.40) | |
| BCLC stage | 0.016 | |
| 0–A (n = 15) | 10.05 (5.41–17.65) | |
| B–C (n = 36) | 14.60 (6.04–30.48) | |
| PVT | 0.242 | |
| Yes (n = 9) | 13.54 (10.42–20.40) | |
| No (n = 26) | 12.00 (6.04–26.54) | |
| Number of tumors | 0.133 | |
| < 3 (n = 44) | 12.63 (5.41–30.48) | |
| > 3 (n = 5) | 15.49 (13.54–18.37) | |
| Tumor size (cm) | 0.080 | |
| ≤ 5 (n = 19) | 12.46 (5.41–18.45) | |
| > 5 (n = 31) | 14.28 (6.04–30.48) | |
| Serum AFP (μg/l) | 0.178 | |
| ≤ 25 (n = 10) | 12.06 (7.59–18.32) | |
| > 25 (n = 38) | 13.80 (5.41–30.48) | |
PHA‐L = biotinylated Phaseolus vulgaris leucoagglutinin; PLA = proximity ligation assay.